Overview

Doxycycline in Cutaneous Schwannoma (NF2)

Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
In this research study we want to learn more about an alternate, local treatment for skin schwannomas. Specifically, we will study local doxycycline injection as a potential treatment for NF2-related skin schwannomas, ultimately reducing the risks and costs associated with standard surgical removal of such skin tumors.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Treatments:
Doxycycline